Published in J Med Virol on October 01, 1998
Identification of the epitopes on HCV core protein recognized by HLA-A2 restricted cytotoxic T lymphocytes. World J Gastroenterol (2001) 0.84
Antigenic heterogeneity of the hepatitis C virus NS5A protein. J Clin Microbiol (2002) 0.78
The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet (2000) 5.38
Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion. J Cell Biol (2000) 2.24
The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. Hum Mol Genet (1996) 2.12
Both emerin and lamin C depend on lamin A for localization at the nuclear envelope. J Cell Sci (2001) 2.01
The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells. Exp Cell Res (2000) 1.89
Direct interaction between emerin and lamin A. Biochem Biophys Res Commun (2000) 1.77
In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide. Nat Biotechnol (2000) 1.65
A two-site ELISA can quantify upregulation of SMN protein by drugs for spinal muscular atrophy. Neurology (2008) 1.58
Tissue distribution of the dystrophin-related gene product and expression in the mdx and dy mouse. Proc Natl Acad Sci U S A (1991) 1.46
Nuclear gems and Cajal (coiled) bodies in fetal tissues: nucleolar distribution of the spinal muscular atrophy protein, SMN. Exp Cell Res (2001) 1.43
Molecular cloning of murine FLT and FLT4. Oncogene (1993) 1.37
Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy. Am J Hum Genet (1993) 1.33
The effect of glucose on insulin biosynthesis by isolated islets of Langerhans of the rat. Biochim Biophys Acta (1970) 1.28
Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin. Am J Hum Genet (1995) 1.27
Monoclonal antibodies against defined regions of the muscular dystrophy protein, dystrophin. FEBS Lett (1990) 1.24
The exon 2b region of the spinal muscular atrophy protein, SMN, is involved in self-association and SIP1 binding. Hum Mol Genet (2000) 1.21
High level synthesis of immunoglobulins in Chinese hamster ovary cells. J Immunol (1990) 1.16
Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in nonmuscle tissues. Proc Natl Acad Sci U S A (1992) 1.14
Characterization of a 4.8kb transcript from the Duchenne muscular dystrophy locus expressed in Schwannoma cells. Hum Mol Genet (1992) 1.14
Rapid mapping by transposon mutagenesis of epitopes on the muscular dystrophy protein, dystrophin. Nucleic Acids Res (1991) 1.14
Monoclonal antibodies for dystrophin analysis. Epitope mapping and improved binding to SDS-treated muscle sections. Biochem J (1992) 1.13
Epitopes in the interacting regions of beta-dystroglycan (PPxY motif) and dystrophin (WW domain). Biochim Biophys Acta (2001) 1.10
Alpha-actinin in nemaline bodies in congenital nemaline myopathy: immunological confirmation by light and electron microscopy. Neuromuscul Disord (1995) 1.10
Screening donor blood for malaria by polymerase chain reaction. Trans R Soc Trop Med Hyg (1995) 1.09
The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies. Neuromuscul Disord (1992) 1.09
Dystrophin-related protein, utrophin, in normal and dystrophic human fetal skeletal muscle. Histochem J (1993) 1.08
Co-localization and molecular association of dystrophin with laminin at the surface of mouse and human myotubes. J Cell Sci (1992) 1.08
A truncated dystrophin lacking the C-terminal domains is localized at the muscle membrane. Am J Hum Genet (1992) 1.07
A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet (1995) 1.07
Monoclonal antibody evidence for structural similarities between the central rod regions of actinin and dystrophin. FEBS Lett (1990) 1.03
Utrophin-dystroglycan complex in membranes of adherent cultured cells. Cell Motil Cytoskeleton (1996) 1.02
Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J Neuropathol Exp Neurol (1993) 1.02
Molecular analysis of a spontaneous dystrophin 'knockout' dog. Neuromuscul Disord (1999) 1.00
Recurrence rates following local anaesthetic day case inguinal hernia repair by junior surgeons in a district general hospital. Ann R Coll Surg Engl (1987) 1.00
Distribution of emerin and lamins in the heart and implications for Emery-Dreifuss muscular dystrophy. Hum Mol Genet (1999) 0.99
Laminin-induced clustering of dystroglycan on embryonic muscle cells: comparison with agrin-induced clustering. J Cell Biol (1997) 0.99
Design of four-helix bundle protein as a candidate for HIV vaccine. Protein Eng (1995) 0.97
Specificity of dystrophin analysis improved with monoclonal antibodies. Lancet (1990) 0.96
Mutations in Emery-Dreifuss muscular dystrophy and their effects on emerin protein expression. Hum Mol Genet (1998) 0.96
The survival motor neuron (SMN) protein: effect of exon loss and mutation on protein localization. Neurogenetics (2000) 0.96
Cell fusion and differentiation in cultured chick muscle cells. Exp Cell Res (1972) 0.94
Hepatitis C epitopes from phage-displayed cDNA libraries and improved diagnosis with a chimeric antigen. J Med Virol (2000) 0.93
Utrophin, the autosomal homologue of dystrophin, is widely-expressed and membrane-associated in cultured cell lines. FEBS Lett (1992) 0.93
Effect of osteoblastic culture conditions on the structure of poly(DL-lactic-co-glycolic acid) foam scaffolds. Tissue Eng (1999) 0.92
Expression and synthesis of alternatively spliced variants of Dp71 in adult human brain. Neuromuscul Disord (2000) 0.92
Monoclonal antibodies against the muscle-specific N-terminus of dystrophin: characterization of dystrophin in a muscular dystrophy patient with a frameshift deletion of exons 3-7. Am J Hum Genet (1993) 0.91
Characterization of a monoclonal antibody panel shows that the myotonic dystrophy protein kinase, DMPK, is expressed almost exclusively in muscle and heart. Hum Mol Genet (2000) 0.90
Structural changes in the C-terminal region of human brain creatine kinase studied with monoclonal antibodies. Biochim Biophys Acta (1991) 0.90
Skeletal muscle pathology in autosomal dominant Emery-Dreifuss muscular dystrophy with lamin A/C mutations. Neuropathol Appl Neurobiol (2001) 0.89
Immunoassay of muscle-specific creatine kinase with a monoclonal antibody and application to myogenesis and muscular dystrophy. Biochem J (1983) 0.89
Successful treatment of catecholaminergic polymorphic ventricular tachycardia with bilateral thoracoscopic sympathectomy. Heart Rhythm (2008) 0.89
Persistence of serum IgA antibodies to herpes simplex, varicella-zoster, cytomegalovirus, and rubella virus detected by enzyme-linked immunosorbent assays. J Med Virol (1985) 0.89
Dystrophin in adult zebrafish muscle. Biochem Biophys Res Commun (2001) 0.88
An internal ribosome binding site can be used to select for homologous recombinants at an immunoglobulin heavy-chain locus. Proc Natl Acad Sci U S A (1991) 0.88
Full-length and short forms of utrophin, the dystrophin-related protein. FEBS Lett (1995) 0.88
Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro. FEBS Lett (1992) 0.88
A survey of post-operative care after day case surgery. Ann R Coll Surg Engl (1996) 0.88
Calcium and the control of muscle-specific creatine kinase accumulation during skeletal muscle differentiation in vitro. Dev Biol (1979) 0.87
A monoclonal antibody against the skeletal muscle enzyme, creatine kinase. FEBS Lett (1982) 0.86
Nucleotide sequences from the capsid and pre-protein regions of dengue viruses from VietNam. Biochem Soc Trans (1997) 0.86
The R482Q lamin A/C mutation that causes lipodystrophy does not prevent nuclear targeting of lamin A in adipocytes or its interaction with emerin. Eur J Hum Genet (2001) 0.86
Selective induction of tumor-associated antigens in murine pulmonary vasculature using double-targeted adenoviral vectors. Gene Ther (2005) 0.86
Colocalization of emerin and lamins in interphase nuclei and changes during mitosis. Biochem Biophys Res Commun (1998) 0.86
Aortic endograft infection: open surgical management with endograft preservation. Eur J Vasc Endovasc Surg (2007) 0.86
Early presentation of X-linked Emery-Dreifuss muscular dystrophy resembling limb-girdle muscular dystrophy. Neuromuscul Disord (1998) 0.85
The N-terminal half of dystrophin is protected from proteolysis in situ. Biochem Biophys Res Commun (1995) 0.85
Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines. Hum Mol Genet (1994) 0.84
Localization of myotonic dystrophy protein kinase in human and rabbit tissues using a new panel of monoclonal antibodies. Hum Mol Genet (1998) 0.84
Significant alterations of biodistribution and immune responses in Balb/c mice administered with adenovirus targeted to CD40(+) cells. Gene Ther (2007) 0.84
Reiterative screening of phage-display peptide libraries with antibodies. Methods Mol Biol (1996) 0.84
Diagnosis of X-linked Emery-Dreifuss muscular dystrophy by protein analysis of leucocytes and skin with monoclonal antibodies. Neuromuscul Disord (1997) 0.84
Design of immunogens as components of a new generation of molecular vaccines. J Biotechnol (1996) 0.83
Hepatitis B in Ho Chi Minh City, Viet Nam. Trans R Soc Trop Med Hyg (1993) 0.83
Monoclonal antibodies to intermediate filaments in chick muscle cell cultures. Exp Cell Res (1985) 0.82
[Monoclonal antibodies cross-reacting with the tick-borne encephalitis virus and with the Venezuelan equine encephalomyelitis virus]. Vopr Virusol (1990) 0.82
Localization of rabbit huntingtin using a new panel of monoclonal antibodies. Brain Res Mol Brain Res (1999) 0.82
Protease digestion studies of an equilibrium intermediate in the unfolding of creatine kinase. Biochem J (1997) 0.81
Monoclonal-antibody studies of creatine kinase. The proteinase K-cleavage site. Biochem J (1985) 0.81
Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin. Am J Med Genet (1995) 0.80
Spatial distribution of "tissue-specific" antigens in the developing human heart and skeletal muscle. I. An immunohistochemical analysis of creatine kinase isoenzyme expression patterns. Anat Rec (1990) 0.80
How does a g993t mutation in the emerin gene cause Emery-Dreifuss muscular dystrophy? Biochem Biophys Res Commun (2001) 0.79
Myocardial dystrophin immunolocalization at sarcolemma and transverse tubules. Experientia (1992) 0.79
Expression of the 43 kDa dystrophin-associated glycoprotein in human neuromuscular disease. Neuromuscul Disord (1994) 0.79
Differential effects of calcium ion concentration on cell fusion, cell division and creatine kinase activity in mucle cell cultures. Exp Cell Res (1976) 0.79
Does the survival motor neuron protein (SMN) interact with Bcl-2? J Med Genet (2000) 0.79
Production of panels of monoclonal antibodies by the hybridoma method. Methods Mol Biol (1996) 0.79
Treatment of human muscle creatine kinase with glutaraldehyde preferentially increases the immunogenicity of the native conformation and permits production of high-affinity monoclonal antibodies which recognize two distinct surface epitopes. J Immunol Methods (1989) 0.79
Isoenzymes of creatine phosphokinase during myogenesis in vitro. Exp Cell Res (1972) 0.78
Fetal dystrophin to diagnose carrier status. Lancet (1991) 0.78
Quantitative changes in creatine kinase isoenzymes during myogenesis in vitro. Biochem Soc Trans (1976) 0.78
Do increases in enzyme activities during muscle differentiation reflect expression of new genes? Nature (1976) 0.78
Biosynthesis of muscle-specific creatine kinase during differentiation in vitro. FEBS Lett (1977) 0.78
Interleukin-11 expression in donor bone marrow cells improves hematological reconstitution in lethally irradiated recipient mice. Exp Hematol (1994) 0.78
The use of creatine kinase activity as an index of skeletal-muscle differentiation. Biochem Soc Trans (1978) 0.78
Problems with LAP nomenclature. Nat Cell Biol (2001) 0.78
Structure of an intermediate in the unfolding of creatine kinase. Proteins (2001) 0.78
Structural relationships between hepatitis B surface antigen in human plasma and dimers from recombinant vaccine: a monoclonal antibody study. Virus Res (1991) 0.78